Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
2017 Annual Report NATIONAL ACADEMY of MEDICINE This page intentionally left blank Contents About the National Academy of Medicine 5 Letter from the President 7 2018-2019 NAM Council 9 Organizational Chart 10 2018-2023 Strategic Plan 11 Program Highlights 13 Responding to Critical and Pressing Issues Collective Action to Combat Clinician Burnout 14 Building an International Scientific Framework for Human Genome Editing 17 Confronting the U.S. Opioid Epidemic 18 Advising the Nation and the World on the Future of Health and Health Care Guiding Policy for Better Health and Health Care 22 Advancing Health Equity 24 Measuring What Matters to Improve the U.S. Health System 27 Building a Framework for Patient- and Family-Engaged Care 28 Ensuring High-Quality Care for High-Need Patients 29 Leading and Inspiring for the Future Sparking Scientific and Social Innovation to Prepare for Global Aging 32 Sharing Science Through Storytelling 33 Enriching the Next Generation of Leaders 34 Member Spotlight 37 Members Inducted in 2017 (Class of 2016) 39 Members Elected in 2017 (Class of 2017) 42 2017 Annual Meeting 44 Richard and Hinda Rosenthal Symposium 45 In Memoriam 46 Awards 47 Gustav O. Lienhard Award for the Advancement of Health Care 48 Rhoda and Bernard Sarnat International Prize in Mental Health 49 Member Awards 50 Publications 51 Finances 59 Donor Recognition 61 Complete Program Listing 81 Contact Information 91 4 About the National Academy of Medicine Founded in 1970 as the Institute of Medicine, the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies). Operating under the 1863 congressional charter of the National Academy of Sciences, the National Academies provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine. The National Academy of Medicine is: An independent, evidence-based scientific advisor. To carry out our work, we harness the talents and expertise of accomplished, thoughtful volunteers and undertake meticulous processes to avoid and balance bias. Our foundational goal is to be the nation’s most reliable source for credible scientific and policy advice on matters concerning human health. A national academy with global scope. Although the National Academies were originally created to advise the U.S. government and advance the well-being of the U.S. population, our mandate is now much broader. The NAM includes members from across the globe and partners with organizations worldwide to address challenges that affect us all. Committed to catalyzing action and achieving impact. We identify and generate momentum around critical issues in health; marshal diverse expertise to build evidence-based solutions; inspire action through collaboration and public engagement; and foster the next generation of leaders and innovators. Collaborative and interdisciplinary. In partnership with the National Academy of Sciences, the National Academy of Engineering, and other stakeholders, the NAM draws on expertise across disciplines and domains to advance science, medicine, technology, and health. An honorific society for exceptional leaders. The NAM has more than 2,000 members elected by their peers in recognition of outstanding achievement. Through a commitment to volunteer service, NAM members help guide the work and advance the mission of the NAM and the National Academies. 5 NAM President Victor J. Dzau, MD, addresses members at the 2017 Annual Meeting. 6 Letter from the President For nearly 50 years, since its founding as the Institute of Medicine, the National Academy of Medicine (NAM) has been committed to upholding the essential role of science and evidence in improving human health. Today, amid unprecedented challenges in the Following the tragic mass shootings in Las United States and worldwide—from the ero- Vegas and Parkland, we drew on the 2013 sion of scientific authority in public discourse report Priorities for Research to Reduce the to devastating natural disasters, infectious Threat of Firearm-Related Violence to urge the disease outbreaks, and gun violence—that adoption of a thorough public health research foundational commitment has never been agenda to stem the epidemic of violence. more important. I am pleased that Congress clarified the In this report, we share recent highlights spending bill provision known as the Dickey from the NAM’s programs, which are Amendment, which had acted as a decades- working to advance science, inform policy, long legislative barrier to federally funded and improve health across many fronts. We firearm research. Finally, there is a pathway to also acknowledge the contributions of NAM an evidence-based analysis of one of the most members, volunteers, and donors in 2017, important issues of our time. whose expertise, commitment, and support Of course, we must do far more than look makes our important work possible. to our past work to inform current challenges. During the past year, we spoke out more As we approach the 50th anniversary of our strongly than ever before in defense of science founding in 1970, we are turning our attention and evidence as the north star for effective to the next five decades and mapping the policy making. As challenges emerged, I am greatest priorities and opportunities in proud that we were able to respond quickly health. We have just completed a strategic with authoritative guidance. For example, plan (described further on page 11) to guide when misinformation spread about health our work and build an infrastructure that will risks from vaccines—leading to a preventable sustain our mission for decades to come. outbreak of measles in Michigan—we Among several overarching goals is the redistributed our extensive body of evidence imperative to “lead and inspire action on on vaccines’ proven safety and immense bold ideas to impact science, medicine, societal benefit. policy, and health equity domestically and After the catastrophic string of hurricanes in globally.” We are preparing to face some of Florida, Texas, and Puerto Rico, we leveraged the monumental challenges and opportunities our series of reports on disaster preparedness before us, such as the aging global population, and response to advise officials from the U.S. the fragility of our ecosystems, the growing Department of Health and Human Services threat of pandemic disease, and technological and the Federal Emergency Management frontiers that were unimaginable just a few Agency about how to rebuild communities to years ago. promote better health and greater resilience in the future. Continued 7 To meet the needs of the future, we address disparities in health and access to must break down barriers and embrace care worldwide. We must create policy and the convergence of scientific disciplines. incentives that reward innovation and ensure We must equip the scientific and medical scientific advancement. And we must build workforces of the future with the appropriate the tools and mindset required to confront skills and an ethical framework to navigate a multitude of challenges we cannot yet a rapidly changing landscape. We must anticipate. I look forward with pride and determination to another year of progress toward our vision—a healthier future for everyone. Victor J. Dzau, MD 8 2018-2019 NAM Council The National Academy of Medicine is governed by a Council composed of NAM members elected by the membership. Victor J. Dzau, MD (Chair) R. Alta Charo, JD, Warren P. Lynn R. Goldman, MD, Margaret Hamburg, MD Knowles Professor of Law & MPH, Dean, School of Public (Foreign Secretary); President, Bioethics, School of Law and Health and Health Services; American Association for the Department of Medical History Professor, Environmental Advancement of Science and Bioethics, School of Medi- and Occupational Health, The cine and Public Health, Univer- George Washington University Jane E. Henney, MD sity of Wisconsin–Madison (Home Secretary) Eve J. Higginbotham, MD, Angela Diaz, MD, MPH, Vice Dean, Inclusion and Di- Keith R. Yamamoto, PhD Jean C. and James W. Crystal versity; Senior Fellow, Leonard (Vice Chair); Vice Chancellor for Professor of Adolescent Health, Davis Institute of Health Eco- Science Policy and Strategy; Department of Pediatrics and nomics; Professor of Ophthal- Vice Dean for Research, School Department of Preventive mology, Scheie Eye Institute; of Medicine; Professor, Cellular Medicine, Icahn School of Medi- Perelman School of Medicine, & Molecular Pharmacology, cine at Mount Sinai University of Pennsylvania University of California, San Francisco Mark C. Fishman, MD, Raynard Kington, MD, PhD, Professor of Stem Cell and President, Grinnell College Nancy Andrews, PhD, MD, Regenerative Biology, Harvard Story Landis, PhD, Scientist Vice Chancellor and Dean, University Duke University School of Emeritus, National Institute of Medicine Linda P. Fried, MD, MPH, Neurological Disorders and Dean and DeLamar Profes- Stroke Jeffrey R. Balser, MD, PhD, sor of Public Health, Joseph Albert Reece, MD, PhD, President and CEO, Vanderbilt L. Mailman School of Public University Medical Center; MBA, Vice President for Health, Columbia University; Medical Affairs, University of Dean, School of Medicine, Professor of